| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.05 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |